Soleno Therapeutics, Inc.
(NASDAQ : SLNO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.72%148.250.7%$1026.38m
MDTMedtronic Plc
0.81%113.110.6%$495.86m
ABTAbbott Laboratories
0.27%85.470.8%$370.08m
TMOThermo Fisher Scientific, Inc.
1.28%320.051.0%$358.51m
ISRGIntuitive Surgical, Inc.
0.82%585.572.4%$318.70m
BDXBecton, Dickinson & Co.
0.68%260.671.1%$311.81m
DXCMDexCom, Inc.
-0.90%224.768.3%$300.02m
SYKStryker Corp.
0.40%204.021.3%$256.03m
EWEdwards Lifesciences Corp.
-1.67%238.901.2%$245.61m
BSXBoston Scientific Corp.
1.90%44.081.1%$234.11m
BAXBaxter International, Inc.
0.88%83.211.8%$208.89m
PODDInsulet Corp.
-0.15%183.966.7%$176.56m
MTDMettler-Toledo International, Inc.
3.34%761.435.4%$168.33m
HOLXHologic, Inc.
0.88%52.741.7%$160.98m
ALGNAlign Technology, Inc.
0.43%275.726.4%$153.84m

Company Profile

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.